Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Mistral AI Acquires Emmi AI to Expand Industrial AI Solutions in Europe
Analog Devices Nears $1.5B Acquisition of AI Chip Firm Empower Semiconductor
Intuit Raises Full-Year Forecast After Strong Q3 Earnings Despite Stock Drop
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition
GameStop Raises eBay Stake to 6.6% as Ryan Cohen Pushes $56 Billion Takeover Bid
Texas Sues Meta Over WhatsApp Encryption Claims
SpaceX Eyes AI Computing Expansion Ahead of Historic IPO
OpenAI Expands Globally with First Overseas AI Lab in Singapore
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace
Anthropic Revenue Surge Signals Strong AI Market Momentum in 2026
Samsung Union Confirms 18-Day Strike After Failed Wage Talks
NHS shakeup: if it sounds like we’ve been here before, it’s because we have
Tencent Shares Jump 4% as AI Models Move Toward Paid Commercial Services
X Corp Loses Legal Battle Over Australia Child Safety Fine 



